Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10420800 Immunotherapy against neuronal and brain tumors
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
November 20, 2018
0
Date of Patent
September 24, 2019
0
Patent Application Number
16196402
0
Patent Citations Received
US Patent 11840562 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
0
US Patent 10695411 Method of treating with a peptide
0
US Patent 11547750 Peptides and T cells for use in immunotherapeutic treatment hepatocellular carcinoma
US Patent 11559572 Peptides and T cells for use in immunotherapeutic treatment of various cancers
US Patent 10898558 Method of treating with a peptide
US Patent 11576954 Method for treating non-small lung cancer with a population of activated cells
US Patent 11065316 Peptides and T cells for use in immunother[[r]]apeutic treatment of various cancers
US Patent 11607446 Personalized immunotherapy against several neuronal and brain tumors
0
US Patent 11744882 Peptides and T cells for use in immunotherapeutic treatment of various cancers
US Patent 11759507 Personalized immunotherapy against several neuronal and brain tumors
•••
Patent Inventor Names
Claudia Trautwein
0
Oliver Schoor
0
Steffen Walter
0
Toni Weinschenk
0
Harpreet Singh
0
Norbert Hilf
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10420800
0
Patent Primary Examiner
Kimberly Ballard
0
Find more entities like US Patent 10420800 Immunotherapy against neuronal and brain tumors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE